• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
  • Subscribe
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services

Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations

Medical Cannabis (ASX:CPH)

Creso Pharma Share Price is Flat on Halucenex Update (ASX:CPH)

By Lachlann Tierney, Monday, 19 April 2021

The Creso Pharma Ltd [ASX:CPH] share price is trading flat despite updates on Halucenex and Californian legalisation of psychedelics. The CPH share price is down 1%…

ASX MYX - Mayne Pharma Shares

Mayne Pharma Share Price Up, Thanks to FDA Approval (ASX:MYX)

By Ryan Clarkson-Ledward, Friday, 16 April 2021

The Mayne Pharma Group Ltd [ASX:MYX] share price opened 22% higher this morning following a favourable announcement. But this early bullishness has waned as the trading day has gone on…

Vaccine Turmoil Won’t Derail Recovery - Not All Vaccines are The Same

Vaccine Turmoil Won’t Derail Recovery — Social Factors of New Money

By Lachlann Tierney, Wednesday, 14 April 2021

In today’s Money Morning…known knowns: we have effective vaccines…known unknowns: virus variants will emerge…unknown unknowns: social factors of ‘new money’…and more…

ASX ADO - AnteoTech Share Price

Green-light for AnteoTech COVID-19 Test Sends Shares Up (ASX:ADO)

By Ryan Clarkson-Ledward, Monday, 12 April 2021

It’s a case of back-to-back wins for nanotech stock AnteoTech Ltd [ASX:ADO]. The ADO share price is rising for a different reason. With the ongoing efforts of a novel COVID-19 test responsible for the upbeat outlooks.

Is the ‘Value Rotation’ Over Already? — Speculative Growth Stocks

Is the ‘Value Rotation’ Over Already? — The Value Stocks Outlook

By Ryan Clarkson-Ledward, Friday, 09 April 2021

The value stocks have been on the rise recently. Ever since late last year, we’ve been seeing markets and investors re-evaluate their portfolios. Driven by fears of inflation and rising bond yields…

ASX IMM Share Price Up - Immutep

Immutep Share Price Soars on US FDA Fast Track Designation (ASX:IMM)

By Lachlann Tierney, Thursday, 08 April 2021

The Immutep Ltd [ASX:IMM] share price is up 11.4% today after securing fast track designation from the US FDA for its eftilagimod alpha product. IMM shares were up as much as 17% in early trade…

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Interim pages omitted …
  • Page 28
  • Go to Next Page »

Primary Sidebar

Technology Categories

  • Technology
  • Artificial Intelligence
  • Bitcoin
  • Cryptocurrency
  • Energy
  • Financial Technology
  • Bio Technology

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988